Antiphospholipid Syndrome Committee of the Brazilian Society of Rheumatology position statement on the use of direct oral anticoagulants (DOACs) in antiphospholipid syndrome (APS)

Balbi, Gustavo Guimarães Moreira; Pacheco, Marcelo de Souza; Monticielo, Odirlei Andre; Funke, Andreas; Danowski, Adriana; Santiago, Mittermayer Barreto; Staub, Henrique Luiz; Rêgo, Jozelia; de Andrade, Danieli Castro Oliveira

doi:10.1186/s42358-020-00125-9

Advances in Rheumatology

Article metrics
Last updated: Thu, 25 Apr 2024 22:17:23 Z

Antiphospholipid Syndrome Committee of the Brazilian Society of Rheumatology position statement on the use of direct oral anticoagulants (DOACs) in antiphospholipid syndrome (APS)

Access & Citations

6773

Article Accesses
2

Web of Science
5

CrossRef

Citation counts are provided from Web of Science and CrossRef. The counts may vary by service, and are reliant on the availability of their data. Counts will update daily once available.

ISSN: 2523-3106

Contact us

Submission enquiries: Access here and click Contact Us
General enquiries: info@biomedcentral.com